Savvy Stock Picks

Citrix Systems, Inc. (NASDAQ:CTXS) slid -0.41%, currently trading at $67.77 and its overall traded volume is 497,945.00 shares while reporting at 11:00 AM on Tuesday, against its average volume of 1.94M. CTXS opened the day at $68.13, it made an intraday low of $67.57 and an intraday high of $68.46. The stock has a 52 week low of $40.33 and 52 week high of $71.93. At current market price, the market capitalization of the company stands at 12.73B and it has 187.77M outstanding shares.Citrix Systems, Inc. (Citrix) designs, develops and markets technology solutions that enable information technology (IT) services to be delivered through its virtual computing infrastructure on demand, independent of location, device or network. During the year ended December 31, 2009, Citrix serves over 230,000 customers and over 100 million users in over 100 countries. Its products and services include desktop solutions, which include XenDesktop, XenApp, and online services, which include GoToMeeting, GoToTraining, GoToAssist and GoToMyPC, and Datacenter and Cloud Solutions, which include CitrixXenServer and Citrix Essentials for XenServer and Hyper-V.

Euro Tech Holdings Co. Ltd. (NASDAQ:CLWT) surged 20.34%, currently trading at $1.42 and its overall traded volume is 497,548.00 shares while reporting at 11:00 AM on Tuesday, against its average volume of 25,917.00. CLWT opened at $1.20 and is trading within the range of $1.20-$1.55. The stock has a 52 week low of $1.00 and 52 week high of $2.57. CLWT’s market capitalization is 16.39M and it has 11.55M outstanding shares.Euro Tech Holdings Company Limited is a distributor of a range of advanced water treatment equipment (including chlorination equipment), laboratory instruments, analyzers, test kits and related supplies and power generation equipment (including recorders and power quality analyzers). The Company acts as an exclusive and non-exclusive distributor for manufacturers of such equipment, primarily to commercial customers and governmental agencies or instrumentalities in Hong Kong and the People’s Republic of China (PRC). The Company distributes products through retail shops and representative offices located in Beijing, Shanghai, Guangzhou, Chongqing, Xi’An, Shenyang, Wuhan, Fuzhou, Chengdu and Urumqi and through non-exclusive arrangements with independent sub-distributors located in Hong Kong, the PRC and Macau. Euro Tech (Far East) Limited (Far East) is the principal operating subsidiary of the Company.

StemCells, Inc. (NASDAQ:STEM) soared 0.00%, currently trading at $1.02 and its overall traded volume is 494,837.00 shares while reporting at 11:00 AM on Tuesday, with the total traded volume of 1.67M shares. STEM shares were trading within the range of $1.02-$1.03 while its opening price is $1.03. The 52-week range of the stock is $0.75-$1.45. The market capitalization of the company stands at 129.57M and it has 127.03M outstanding shares.StemCells, Inc. (StemCells) is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry. The Company is focused on cellular medicine, or the use of stem and progenitor cells as the basis for therapeutics and therapies, and enabling technologies for stem cell research, or the use of cells and related technologies to enable stem cell-based research and drug discovery and development. The primary research and development efforts are focused on cellular medicine, where StemCells seeks to identify and develop stem and progenitor cells as therapeutic agents. It has two therapeutic product development programs: the CNS Program, which is developing applications for HuCNS-SC cells, the human neural stem cell product candidate, and the Liver Program, which is developing the applications for the human liver engrafting cells.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) fell -1.98%, currently trading at $1.60 and its overall traded volume is 498,882.00 shares while reporting at 11:00 AM on Tuesday, against its average volume of 1.59M. ACAD shares were trading within the range of $1.50-$1.66 while its opening price is $1.56. The 52-week range of the stock is $0.65-$2.00. The market capitalization of the company stands at 62.88M and it has 39.30M outstanding shares.ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson’s disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer’s disease psychosis, for which it is initiating a Phase II feasibility study.

Patterson-UTI Energy, Inc. (NASDAQ:PTEN) gained 1.21%, currently trading at $20.76 and its overall traded volume is 493,987.00 shares while reporting at 11:00 AM on Tuesday, the stock has average daily volume of 2.81M shares. PTEN opened the day at $20.53, it made an intraday low of $20.43 and an intraday high of $20.76. The stock has a 52-week range of $11.85-$22.67. The market capitalization of the company stands at 3.20B and it has 154.13M outstanding shares.Patterson-UTI Energy, Inc. (Patterson-UTI) owns and operates fleets of land-based drilling rigs in the United States. The Company’s contract drilling business operates primarily in Texas, New Mexico, Oklahoma, Arkansas, Louisiana, Mississippi, Colorado, Utah, Wyoming, Montana, North Dakota, Pennsylvania, West Virginia and western Canada. As of December 31, 2009, it had a drilling fleet that consisted of 341 marketable land-based drilling rigs. It provides pressure pumping services to oil and natural gas operators primarily in the Appalachian Basin. These services consist primarily of well stimulation and cementing for completion of new wells and remedial work on existing wells. It also owns and invests in oil and natural gas assets as a working interest owner. Its oil and natural gas interests are located primarily in Texas and New Mexico. The Company exited the drilling and completion fluids services business on January 20, 2010, and sold substantially all of the assets.